Accès à distance ? S'identifier sur le proxy UCLouvain
LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
Primary tabs
| Document type | Article de périodique (Journal article) – Article de recherche |
|---|---|
| Access type | Accès restreint |
| Publication date | 2005 |
| Journal information | "Current Medical Research and Opinion" - Vol. 21, no. 4, p. 571-578 (2005) |
| Peer reviewed | yes |
| Publisher | Informa Healthcare (London) |
| issn | 0300-7995 |
| e-issn | 1473-4877 |
| Publication status | Publié |
| Affiliations |
UCL
- MD/MINT - Département de médecine interne UCL - (SLuc) Service de cardiologie |
| MESH Subject | Administration, Oral ; Aged ; Anticholesteremic Agents - therapeutic use ; Azetidines - therapeutic use ; Cholesterol, LDL - blood - drug effects ; Coronary Disease - complications ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Hypercholesterolemia - drug therapy ; Male ; Middle Aged ; Placebos ; Simvastatin - therapeutic use ; Treatment Outcome |
| Links |
| Bibliographic reference | Brohet, Christian ; Banai, S ; Alings, A M W ; Massaad, R ; Davies, M J ; et. al. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.. In: Current Medical Research and Opinion, Vol. 21, no. 4, p. 571-578 (2005) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/29479 |